Benzodiazepine toxicity: Difference between revisions

(Add MedicationDose SMW entry for flumazenil; dose verified against toxicology references)
 
Line 39: Line 39:
*Flumazenil-Induced Seizure
*Flumazenil-Induced Seizure
**Treat with [[phenobarbital]] or [[propofol]]; benzodiazepines will not work
**Treat with [[phenobarbital]] or [[propofol]]; benzodiazepines will not work
==Medication Dosing==
*{{MedicationDose|drug=Flumazenil|dose=0.2 mg IV, repeat q1min|route=IV|context=Benzodiazepine antagonist (controversial)|indication=Benzodiazepine toxicity|population=Adult|max_dose=3 mg|notes=Contraindicated in chronic benzo use, TCA coingesion, seizure disorder}}


==Disposition==
==Disposition==

Latest revision as of 17:59, 20 March 2026

Background

  • Isolated benzodiazepine overdose has low morbidity/mortality
    • Coingestion or parenteral administration accounts for vast majority of deaths
    • Respiratory depression rare with overdose of oral agents

Clinical Features

  • Somnolence, slurred speech, ataxia (similar to ETOH intoxication)
  • Paradoxical reaction (more common in hyperactive children, psychiatric patients)
  • Hypotension
  • Respiratory depression

Differential Diagnosis

Sedative/hypnotic toxicity

Evaluation

Management

Flumazenil

  • Controversial
  • Indication:
    • Consider (though controversial) for coma reversal
  • Contraindications:
    • Suspected or known physical dependence on benzodiazepines
    • Suspected TCA overdose
    • Co-ingestion of seizure-inducing agents
    • Known seizure disorder
    • Suspected increased intracranial pressure
  • Dosing
    • 0.2mg IV; may repeat q1min (max dose 3mg)
  • Flumazenil-Induced Seizure


Medication Dosing

  • Flumazenil 0.2 mg IV, repeat q1min IV (max 3 mg) — Contraindicated in chronic benzo use, TCA coingesion, seizure disorder

Disposition

  • Consider discharge after 6hr observation

See Also

References